Cargando…

Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review

Chemokines are known to be immunoregulatory proteins involved not only in lymphocyte chemotaxis to the site of inflammation, but also in neuromodulation, neurogenesis, and neurotransmission. Multiple lines of evidence suggest a peripheral proinflammatory state and neuroinflammation in at least a thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ermakov, Evgeny A., Mednova, Irina A., Boiko, Anastasiia S., Buneva, Valentina N., Ivanova, Svetlana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917146/ https://www.ncbi.nlm.nih.gov/pubmed/36768537 http://dx.doi.org/10.3390/ijms24032215

Ejemplares similares

Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers
por: Kozyrev, Evgeny A., et al.
Publicado: (2023)

Association of Peripheral Inflammatory Biomarkers and Growth Factors Levels with Sex, Therapy and Other Clinical Factors in Schizophrenia and Patient Stratification Based on These Data
por: Ermakov, Evgeny A., et al.
Publicado: (2023)

Serum Growth Factors in Schizophrenia Patients
por: Boiko, Anastasiia S., et al.
Publicado: (2023)

Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
por: Ermakov, Evgeny A., et al.
Publicado: (2022)

Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia
por: Mednova, Irina A., et al.
Publicado: (2022)

Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome
por: Boiko, Anastasiia S., et al.
Publicado: (2023)

Metabolic Hormones in Schizophrenia Patients with Antipsychotic-Induced Metabolic Syndrome
por: Boiko, Anastasiia S., et al.
Publicado: (2022)

Development of approaches to stratification of patients with schizophrenia based on cytokine levels using cluster analysis
por: Ermakov, E., et al.
Publicado: (2022)

Cortisol and DHEAS Related to Metabolic Syndrome in Patients with Schizophrenia
por: Boiko, Anastasiia S, et al.
Publicado: (2020)

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia
por: Boiko, Anastasiia S., et al.
Publicado: (2019)

The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia
por: Kamaeva, Daria A., et al.
Publicado: (2023)

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia
por: Mednova, Irina A., et al.
Publicado: (2020)

Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis
por: Melamud, Mark M., et al.
Publicado: (2023)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia
por: Ermakov, Evgeny A., et al.
Publicado: (2017)

Multiplex Analysis of Serum Cytokine Profiles in Systemic Lupus Erythematosus and Multiple Sclerosis
por: Melamud, Mark M., et al.
Publicado: (2022)

Natural Catalytic IgGs Hydrolyzing Histones in Schizophrenia: Are They the Link between Humoral Immunity and Inflammation?
por: Ermakov, Evgeny A., et al.
Publicado: (2020)

Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States
por: Ermakov, Evgeny A., et al.
Publicado: (2020)

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome
por: Boiko, Anastasiia S., et al.
Publicado: (2022)

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals
por: Kornetova, Elena G., et al.
Publicado: (2021)

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia
por: Paderina, Diana Z., et al.
Publicado: (2021)

DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia
por: Ermakov, Evgeny A., et al.
Publicado: (2015)

Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome
por: Kornetova, Elena G., et al.
Publicado: (2019)

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia
por: Paderina, Diana Z., et al.
Publicado: (2022)

Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
por: Boiko, Anastasiia S, et al.
Publicado: (2021)

Substrate specificity of healthy human sera IgG antibodies with peroxidase and oxydoreductase activities
por: Tolmacheva, Anna S., et al.
Publicado: (2018)

Natural catalytic immunoglobulins hydrolyzing histones as a link between inflammation and humoral immunity in schizophrenia
por: Ermakov, E., et al.
Publicado: (2021)

Association of Single Nucleotide Polymorphisms of Cytokine Genes with Depression, Schizophrenia and Bipolar Disorder
por: Mikhalitskaya, Ekaterina V., et al.
Publicado: (2023)

IgGs-Abzymes from the Sera of Patients with Multiple Sclerosis Recognize and Hydrolyze miRNAs
por: Ermakov, Evgeny A., et al.
Publicado: (2021)

MicroRNAs of Milk in Cells, Plasma, and Lipid Fractions of Human Milk, and Abzymes Catalyzing Their Hydrolysis
por: Kompaneets, Ivan Yu., et al.
Publicado: (2022)

Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia
por: Parshukova, Daria A., et al.
Publicado: (2020)

Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome
por: Mednova, Irina A., et al.
Publicado: (2022)

IgGs-Abzymes from the Sera of Patients with Systemic Lupus Erythematosus Hydrolyzed miRNAs
por: Ermakov, Evgeny A, et al.
Publicado: (2020)

IgGs from Human Milk Hydrolyze microRNAs
por: Kompaneets, Ivan Yu., et al.
Publicado: (2020)

Amino Acid and Acylcarnitine Levels in Chronic Patients with Schizophrenia: A Preliminary Study
por: Mednova, Irina A., et al.
Publicado: (2021)

Immunoglobulins G of Patients with Schizophrenia Protects from Superoxide: Pilot Results
por: Mednova, Irina A., et al.
Publicado: (2022)

IgG-Dependent Dismutation of Superoxide in Patients with Different Types of Multiple Sclerosis and Healthy Subjects
por: Smirnova, Liudmila P., et al.
Publicado: (2020)

Superoxide dismutase activity of serum IgG in acute illness and remission period of schizophrenia
por: Mednova, I., et al.
Publicado: (2022)

Lymphoid chemokines in chronic neuroinflammation
por: Aloisi, Francesca, et al.
Publicado: (2008)

The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders
por: Lindsay, Hunter G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_21pcbj3p33sqcuml5it1i8uqg7